Clinical Trial Update: Patient Preference of h-Patch vs. Pen or Needle/Syringe as Insulin Administration Device [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing patient preference for the h-Patch insulin delivery device versus pen or needle/syringe in Type 1 and Type 2 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• h-Patch insulin delivery device (h-Patch)

Snippet

Sponsor: Valeritas, Inc. | Conditions: Type 1 Diabetes, Type 2 Diabetes | Phase 4 | Status: TERMINATED